VOR – vor biopharma inc. (US:NASDAQ)
Stock Stats
News
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Vor Bio to Participate in Upcoming Investor Conferences
Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation [Yahoo! Finance]
Form 4 Vor Biopharma Inc. For: May 01 Filed by: ANG ROBERT
Form 4 Vor Biopharma Inc. For: May 01 Filed by: Attar Eyal C.
Form 4 Vor Biopharma Inc. For: May 01 Filed by: Jorgensen Nathan D.
Form 4 Vor Biopharma Inc. For: May 01 Filed by: Chakraborty Tirtha
Form 4 Vor Biopharma Inc. For: Apr 30 Filed by: Namouni Fouad
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.